Charles  Fitzgerald net worth and biography

Charles Fitzgerald Biography and Net Worth

Director of Global Medical REIT

Mr. Fitzgerald has served as a Director since May 2026. Mr. Fitzgerald is the Founder and Managing Partner of Maewyn Capital Partners LLC. Prior to forming Maewyn, he was the Founder, Managing Partner and Co-Portfolio Manager of V3 Capital Management LP, and previously held senior investment roles at High Rise Capital Management, JP Morgan Fleming Asset Management and Prudential Real Estate Investors. Mr. Fitzgerald has nearly 30 years of experience investing across public and private real estate markets.

He currently serves on the Board of Directors of FrontView REIT, Inc. (FVR) and on the Board of Vibrant Emotional Health, a nonprofit focused on emotional wellness and the administrator of the national 988 Suicide & Crisis Lifeline. Mr. Fitzgerald holds a Bachelor of Arts in Finance and Economics from Northern State University and is a CFA charterholder.

What is Charles Fitzgerald's net worth?

The estimated net worth of Charles Fitzgerald is at least $4.58 million as of August 10th, 2026. Fitzgerald owns 124,893 shares of Global Medical REIT stock worth more than $4,577,328 as of August 12th. This net worth approximation does not reflect any other assets that Fitzgerald may own. Learn More about Charles Fitzgerald's net worth.

How do I contact Charles Fitzgerald?

The corporate mailing address for Fitzgerald and other Global Medical REIT executives is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. Global Medical REIT can also be reached via phone at (202) 524-6851 and via email at [email protected]. Learn More on Charles Fitzgerald's contact information.

Has Charles Fitzgerald been buying or selling shares of Global Medical REIT?

During the past quarter, Charles Fitzgerald has bought $991,944.00 in Global Medical REIT stock. Most recently, on Monday, August 10th, Charles Fitzgerald bought 27,600 shares of Global Medical REIT stock. The stock was acquired at an average cost of $35.94 per share, with a total value of $991,944.00. Following the completion of the transaction, the director now directly owns 124,893 shares of the company's stock, valued at $4,488,654.42. Learn More on Charles Fitzgerald's trading history.

Who are Global Medical REIT's active insiders?

Global Medical REIT's insider roster includes Jeffrey Busch (CEO), Paula Crowley (Director), Mark Decker, Jr. (CEO), Charles Fitzgerald (Director), and Charles Fitzgerald (Director). Learn More on Global Medical REIT's active insiders.

Are insiders buying or selling shares of Global Medical REIT?

In the last year, Global Medical REIT insiders bought shares 10 times. They purchased a total of 56,844 shares worth more than $1,988,572.90. The most recent insider tranaction occured on August, 10th when CEO Mark Okey Decker Jr bought 8,000 shares worth more than $287,040.00. Insiders at Global Medical REIT own 8.9% of the company. Learn More about insider trades at Global Medical REIT.

Information on this page was last updated on 8/10/2026.

Charles Fitzgerald Insider Trading History at Global Medical REIT

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2026Buy27,600$35.94$991,944.00124,893View SEC Filing Icon  
See Full Table

Charles Fitzgerald Buying and Selling Activity at Global Medical REIT

This chart shows Charles Fitzgerald's buying and selling at Global Medical REIT by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Global Medical REIT Company Overview

Global Medical REIT logo
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More

Today's Range

Now: $36.68
Low: $36.00
High: $37.24

50 Day Range

MA: $36.54
Low: $34.90
High: $38.10

2 Week Range

Now: $36.68
Low: $29.05
High: $39.93

Volume

121,545 shs

Average Volume

120,141 shs

Market Capitalization

$485.28 million

P/E Ratio

9.86

Dividend Yield

5.35%

Beta

1.09